Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
1.
Obes Surg ; 28(5): 1377-1384, 2018 05.
Article in English | MEDLINE | ID: mdl-29236206

ABSTRACT

BACKGROUND: A lack of clarity remains over the optimal strategy for the management of laparoscopic adjustable gastric band (LAGB) slippage, which, although rare (around 3% in our experience), can when acute result in obstruction, gastric erosion or ischaemia. Typically, slipped bands are removed acutely. The aim of this study was to explore outcomes following immediate or delayed resiting of slipped LAGBs in a single centre, comparing simple repositioning with retunnelling and replacement. METHODS: A retrospective analysis of computerised records, notes and prospectively maintained bariatric databases was undertaken to identify all patients with a slipped LAGB in a single centre. RESULTS: Thirty-two patients required operative intervention following a diagnosis of slipped LAGB (median time from initial LAGB insertion to slippage 2.9 years). Two (6%) patients underwent band removal and 30 (94%), band revision surgery (25 immediately and five at a planned but expedited procedure).Twenty-four (77%) patients underwent insertion of a new LAGB via a de novo retrogastric tunnel, five (21%) of which required further future operative intervention; whereas, six (23%) patients underwent repositioning of the existing LAGB within the same tunnel, five (83%) of which underwent further operative intervention (log-rank test p = 0.0001). Following LAGB revision, there was no significant further change in BMI (median + 1 kg/m2; range - 13 to + 10 kg/m2). CONCLUSION: Resiting of slipped LAGBs is safe and maintains weight loss. Although a significant risk of future operative intervention remains, this can be reduced via the creation of a de novo retrogastric tunnel for band resiting.


Subject(s)
Bariatric Surgery/adverse effects , Obesity, Morbid/surgery , Reoperation/statistics & numerical data , Adult , Aged , Female , Humans , Laparoscopy/methods , Male , Middle Aged , Reoperation/methods , Retrospective Studies , Weight Loss , Young Adult
2.
Soc Psychiatry Psychiatr Epidemiol ; 46(1): 35-44, 2011 Jan.
Article in English | MEDLINE | ID: mdl-19916062

ABSTRACT

BACKGROUND: Understanding the determinants of major depression in sub-Saharan Africa is important for planning effective intervention strategies. OBJECTIVE: To investigate the social and life-event determinants of major depressive disorder in the African sociocultural context of rural Uganda. METHODS: A cross-section survey was carried out in 14 districts in Uganda from 1 June 2003 to 30 October 2004. 4,660 randomly selected respondents (15 years and above) were interviewed. The primary outcome was the presence of 'probable major depressive disorder' (PMDD) as assessed by the Hopkins symptom checklist. RESULTS: The prevalence of PMDD was 29.3% (95% confidence interval, 28.0-30.6%). Factors independently associated with depression in both genders included: the ecological factor, district; age (increase with each age category after 35 years); indices of poverty and deprivation (no formal education, having no employment, broken family, and socioeconomic classes III-V). Only a few adverse life events, notably those suggestive of a disrupted family background (death of a father in females and death of a mother in males) were associated with increased risk. CONCLUSION: Socioeconomic and sociodemographic factors, operating at both ecological and the individual level are the strongest independent determinants of depression. Adverse life events were less strongly associated with depression in this sample.


Subject(s)
Depressive Disorder, Major/epidemiology , Life Change Events , Poverty/statistics & numerical data , Adolescent , Adult , Africa South of the Sahara/epidemiology , Age Distribution , Cross-Sectional Studies , Depressive Disorder, Major/psychology , Female , Humans , Male , Middle Aged , Poverty/psychology , Prevalence , Risk Factors , Rural Population/statistics & numerical data , Socioeconomic Factors , Uganda/epidemiology
3.
Lancet ; 377(9759): 52-62, 2011 Jan 01.
Article in English | MEDLINE | ID: mdl-21176950

ABSTRACT

BACKGROUND: Helminth infections affect the human immune response. We investigated whether prenatal exposure to and treatment of maternal helminth infections affects development of an infant's immune response to immunisations and unrelated infections. METHODS: In this randomised, double-blind, placebo-controlled trial, we enrolled 2507 women in the second or third trimester of pregnancy who were planning to deliver in Entebbe General Hospital, Entebbe, Uganda. With a computer-generated random number sequence in blocks of 100, we assigned patients to 440 mg albendazole and 40 mg/kg praziquantel (n=628), 440 mg albendazole and a praziquantel-matching placebo (n=625), 40 mg/kg praziquantel and an albendazole-matching placebo (n=626), or an albendazole-matching placebo and praziquantel-matching placebo (n=628). All participants and hospital staff were masked to allocation. Primary outcomes were immune response at age 1 year to BCG, tetanus, and measles immunisation; incidence of infectious diseases during infancy; and vertical HIV transmission. Analysis was by intention-to-treat. This trial is registered, number ISRCTN32849447. FINDINGS: Data were available at delivery for 2356 women, with 2345 livebirths; 2115 (90%) of liveborn infants remained in follow-up at 1 year of age. Neither albendazole nor praziquantel treatments affected infant response to BCG, tetanus, or measles immunisation. However, in infants of mothers with hookworm infection, albendazole treatment reduced interleukin-5 (geometric mean ratio 0·50, 95% CI 0·30-0·81, interaction p=0·02) and interleukin-13 (0·52, 0·34-0·82, 0·0005) response to tetanus toxoid. The rate per 100 person-years of malaria was 40·9 (95% CI 38·3-43·7), of diarrhoea was 134·1 (129·2-139·2), and of pneumonia was 22·3 (20·4-24·4). We noted no effect on infectious disease incidence for albendazole treatment (malaria [hazard ratio 0·95, 95% CI 0·79-1.14], diarrhoea [1·06, 0·96-1·16], pneumonia [1·11, 0·90-1·38]) or praziquantel treatment (malaria [1·00, 0·84-1·20], diarrhoea [1·07, 0·98-1·18], pneumonia [1·00, 0·80-1·24]). In HIV-exposed infants, 39 (18%) were infected at 6 weeks; vertical transmission was not associated with albendazole (odds ratio 0·70, 95% CI 0·35-1·42) or praziquantel (0·60, 0·29-1·23) treatment. INTERPRETATION: These results do not accord with the recently advocated policy of routine antenatal anthelmintic treatment, and the value of such a policy may need to be reviewed. FUNDING: Wellcome Trust.


Subject(s)
Anthelmintics/administration & dosage , Communicable Diseases/immunology , HIV Infections/immunology , Pregnancy Complications, Parasitic/immunology , Prenatal Exposure Delayed Effects/immunology , Adult , Albendazole/administration & dosage , Albendazole/adverse effects , Anthelmintics/adverse effects , Dose-Response Relationship, Drug , Double-Blind Method , Female , Humans , Infant , Infectious Disease Transmission, Vertical , Praziquantel/administration & dosage , Praziquantel/adverse effects , Pregnancy , Pregnancy Complications, Parasitic/drug therapy , Vaccination , Young Adult
4.
PLoS Negl Trop Dis ; 3(6): e473, 2009 Jun 30.
Article in English | MEDLINE | ID: mdl-19564904

ABSTRACT

BACKGROUND: Infections during pregnancy may have serious consequences for both mother and baby. Assessment of risk factors for infections informs planning of interventions and analysis of the impact of infections on health outcomes. OBJECTIVES: To describe risk factors for helminths, malaria and HIV in pregnant Ugandan women before intervention in a trial of de-worming in pregnancy. METHODS: The trial recruited 2,507 pregnant women between April 2003 and November 2005. Participants were interviewed and blood and stool samples obtained; location of residence at enrolment was mapped. Demographic, socioeconomic, behavioral and other risk factors were modelled using logistic regression. RESULTS: There was a high prevalence of helminth, malaria and HIV infection, as previously reported. All helminths and malaria parasitemia were more common in younger women, and education was protective against every infection. Place of birth and/or tribe affected all helminths in a pattern consistent with the geographical distribution of helminth infections in Uganda. Four different geohelminths (hookworm, Trichuris, Ascaris and Trichostrongylus) showed a downwards trend in prevalence during the enrolment period. There was a negative association between hookworm and HIV, and between hookworm and low CD4 count among HIV-positive women. Locally, high prevalence of schistosomiasis and HIV occurred in lakeshore communities. CONCLUSIONS: Interventions for helminths, malaria and HIV need to target young women both in and out of school. Antenatal interventions for malaria and HIV infection must continue to be promoted. Women originating from a high risk area for a helminth infection remain at high risk after migration to a lower-risk area, and vice versa, but overall, geohelminths seem to be becoming less common in this population. High risk populations, such as fishing communities, require directed effort against schistosomiasis and HIV infection.


Subject(s)
HIV Infections/epidemiology , Helminthiasis/epidemiology , Malaria/epidemiology , Pregnancy Complications, Infectious/epidemiology , Adolescent , Adult , Blood/parasitology , Blood/virology , CD4 Lymphocyte Count , Comorbidity , Feces/parasitology , Feces/virology , Female , Geography , Humans , Medical History Taking , Middle Aged , Parasitemia/epidemiology , Pregnancy , Prevalence , Risk Factors , Uganda/epidemiology , Young Adult
5.
Trop Med Int Health ; 13(5): 680-2, 2008 May.
Article in English | MEDLINE | ID: mdl-18331533

ABSTRACT

OBJECTIVE: To describe uptake of HIV and syphilis testing in a prevention of mother-to-child HIV transmission programme in Uganda. METHODS: Analysis of data from routine HIV and syphilis testing at Entebbe Hospital antenatal services. RESULTS: A total of 20,738 women attended antenatal services. Exactly 62.8% of women, but only 1.8% of their male partners, accepted testing for HIV; 82.2% of women, but only 1.1% of their male partners accepted syphilis testing. Partners of women with positive HIV results were more likely to come for subsequent testing. Of 200 couples whose partners accepted HIV-testing within 30 days of one another, 19 (9.5%) were HIV-discordant, representing 65.5% of couples with at least one partner HIV-positive. HIV prevalence was 12.6% for women and 10.8% for men; syphilis prevalence was 4.0% for women and 6.2% for men. CONCLUSION: Uptake of HIV and syphilis testing was fairly good among pregnant women attending antenatal clinics at Entebbe Hospital, but very low among their male partners. The level of HIV-discordant couples was high. These clinics should be made more couples-friendly to identify both HIV-positive men for treatment and discordant couples for HIV prevention.


Subject(s)
HIV Infections/diagnosis , Infectious Disease Transmission, Vertical/prevention & control , Mass Screening/statistics & numerical data , Pregnancy Complications, Infectious/diagnosis , Prenatal Care/statistics & numerical data , Syphilis/diagnosis , Counseling/statistics & numerical data , Female , HIV Infections/transmission , Humans , Male , Maternal Welfare , Patient Acceptance of Health Care , Pregnancy , Sexual Partners , Syphilis/transmission , Uganda
6.
J Infect Dis ; 197(3): 398-404, 2008 Feb 01.
Article in English | MEDLINE | ID: mdl-18248303

ABSTRACT

BACKGROUND: Currently, there are no comparable estimates of the short-term risk of disease progression in the absence of effective antiretroviral therapy for human immunodeficiency virus (HIV)-infected adults and children. METHODS: A joint analysis of 2 large studies of children with vertically acquired HIV infection (the HIV Paediatric Prognostic Markers Collaborative Study) and adults with seroconversion (the CASCADE [Concerted Action on Sero-Conversion to AIDS and Death in Europe] collaboration) was conducted. Follow-up was censored at the end of 1995, before the introduction of combination antiretroviral therapy. The incidence rates of death and AIDS or death (AIDS/death) were estimated on the basis of age and current CD4 cell count. RESULTS: A total of 1260 deaths (over 20,500 person-years of follow-up) and 1894 initial AIDS events (over 17,200 person-years of follow-up) were observed among 6741 patients (3244 children [i.e., patients < or =15 years of age] and 3497 adults). Young children (age, <5 years) experienced high morbidity and mortality rates. After adjustment for the CD4 cell count, the effect of age on disease progression was not significant among older children, whereas the risk increased markedly in association with increasing age among adults. Death rates were similar among older children and adults aged approximately 20 years, as were the rates of progression to AIDS/death when cases of serious recurrent bacterial infection, which has a more restrictive case definition in adults, were excluded. CONCLUSIONS: Similar CD4 cell count criteria for initiation of antiretroviral therapy can be applied to adults and children > or = 5 years of age.


Subject(s)
Acquired Immunodeficiency Syndrome/epidemiology , Acquired Immunodeficiency Syndrome/immunology , Anti-HIV Agents/therapeutic use , CD4 Lymphocyte Count , HIV Infections/drug therapy , HIV Infections/immunology , Acquired Immunodeficiency Syndrome/mortality , Acquired Immunodeficiency Syndrome/transmission , Adult , Age Distribution , Child , Female , HIV Infections/mortality , HIV Infections/transmission , Humans , Infectious Disease Transmission, Vertical , Male , Meta-Analysis as Topic , Multicenter Studies as Topic , Risk Assessment
7.
Trans R Soc Trop Med Hyg ; 101(9): 899-907, 2007 Sep.
Article in English | MEDLINE | ID: mdl-17555783

ABSTRACT

It is suggested that helminths, particularly hookworm and schistosomiasis, may be important causes of anaemia in pregnancy. We assessed the associations between mild-to-moderate anaemia (haemoglobin >8.0 g/dl and <11.2 g/dl) and helminths, malaria and HIV among 2507 otherwise healthy pregnant women at enrolment to a trial of deworming in pregnancy in Entebbe, Uganda. The prevalence of anaemia was 39.7%. The prevalence of hookworm was 44.5%, Mansonella perstans 21.3%, Schistosoma mansoni 18.3%, Strongyloides 12.3%, Trichuris 9.1%, Ascaris 2.3%, asymptomatic Plasmodium falciparum parasitaemia 10.9% and HIV 11.9%. Anaemia showed little association with the presence of any helminth, but showed a strong association with malaria (adjusted odds ratio (AOR) 3.22, 95% CI 2.43-4.26) and HIV (AOR 2.46, 95% CI 1.90-3.19). There was a weak association between anaemia and increasing hookworm infection intensity. Thus, although highly prevalent, helminths showed little association with mild-to-moderate anaemia in this population, but HIV and malaria both showed a strong association. This result may relate to relatively good nutrition and low helminth infection intensity. These findings are pertinent to estimating the disease burden of helminths and other infections in pregnancy. [Clinical Trial No. ISRCTN32849447].


Subject(s)
Anemia/parasitology , Anemia/virology , HIV Infections/complications , Helminthiasis/complications , Malaria/complications , Pregnancy Complications , Adolescent , Adult , Anemia/epidemiology , Female , HIV Infections/blood , HIV Infections/epidemiology , Helminthiasis/epidemiology , Hemoglobins/analysis , Humans , Malaria/epidemiology , Pregnancy , Pregnancy Complications/epidemiology , Pregnancy Complications/parasitology , Pregnancy Complications/virology , Pregnancy Complications, Hematologic/epidemiology , Pregnancy Complications, Parasitic/epidemiology , Prevalence , Socioeconomic Factors , Treatment Outcome , Uganda/epidemiology
SELECTION OF CITATIONS
SEARCH DETAIL
...